Towards a new paradigm in neuroprotection and neuroplasticity

Brain Protection in Schizophrenia, Mood and Cognitive Disorders

Volumn , Issue , 2010, Pages 27-44

  Muresanu, Dafin F ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

EDA; Neuroplasticity; Neuroprotection; Neurotrophic factors; Pleiotropic and multimodal drugs

Indexed keywords

EID: 84859439731     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-8553-5_2     Document Type: Chapter

References (33)

1. Sloviter R. Apoptosis: a guide for perplexed. Trends Pharmacol Sci 2002;23:19-24
2. Kalivas PW, Volkow ND. The neural basis of addiction: pathology of motivation and choice. Am J Psychiatry 2005;162:1403-1413
3. Muresanu DF. Neurotrophic factors. Bucuresti: Libripress; 2003
4. Muresanu FD. Neuroprotection and neuroplasticity - a holistic approach and future perspectives. J Neurol Sci 2007;257:38-43
5. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005;57:173-185
6. Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol, 2001;13(5):555-562
7. Wu HY, Yuen EY, Lu YF, et al. Regulation of N-Methyl-D-aspartate receptors by calpain in cortical neurons. J Biol Chem 2005;280:21588-21593
8. Hutter-Paier B, Grygar E, Fruhwirth M, Temmel I, Windisch M. Further evidence that Cerebrolysin protects cortical neurons from neurodegeneration in vitro. J Neural Transm Suppl 1998;53:363-372
9. Hetman M, Kharebava G. Survival signaling pathways activated by NMDA receptors. Curr Top Med Chem 2006;6:787-799
10. Brunet A, Datta SR, Greenberg M. E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 2001;11:297-305
11. Hardingham GE, Arnold FJ, Bading H. A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-tonucleus communication. Nat Neurosci 2001;4:565-566
12. Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 2002;5:405-414
13. Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 2004;61:657-668
14. Bano D, Young KW, Guerin CJ, et al. Calpain cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity. Cell 2005;120:275-285
15. Stout AK, Raphael HM, Kanterewicz BI, Klann E, Reynolds IJ. Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat Neurosci 1998;1:366-373
16. Soriano FX, Papadia S, Hofmann F, Hardingham NR, Bading H, Hardingham GE. Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J Neurosci 2006;26:4509-4518
17. Iseda T, Nishio T, Kawaguchi S, et al. Spontaneous regeneration of the corticospinal tract after transection in young rats: a key role of reactive astrocytes in making favourable and unfavourable conditions for regeneration. Neuroscience 2004;126:365-374
18. Kotter MR, Setzu A, Sim FJ, et al. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 2001;35:204-212
19. Masson JL, Jones JJ, Taniike M, Morelll P, Suzuki K, Matsushima GK. Mature oligodendrocytes apoptosis precedes IGF-I production: an oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res 2000;61:251-262
20. Arnett HA, Wang Y, Matsushima GK, Suzuki K, Ting JPY. Functional genomic analysis of remyelination reveals importance of infl ammation in oligodendrocytes regeneration. J Neurosci 2003;23:9824-9832
21. Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel ULM. Tumor necrosis factor (TNF) - mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyld-aspartate receptor activation. J Biol Chem 2004;279(31):32869-32881
22. Becher B, Antel JP. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 1996;18:1-10
23. Windhangen A, Newcombe J, Dan-gond F, Strand C, Woodroofe MNB, Cuzner ML et al. Expression of costimulatory molecules B7-1(CD80), B7-2(CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 1995;182:1985-1996
24. Pachter JS, De Vries HE, Fabry Z. The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol 2003;62:593-604
25. Labiche LA, Grotta JC. Clinical trials for cytoprotection in Stroke. NeuroRx 2004;1:46-70
26. Barnes MP, Dobkin BH, Bogousslavsky J. Recovery after Stroke. New York: Cambridge University Press, 2003
27. Read SJ, Parsons AA, Harrison DC, Philpott K, Kabnick K, O'Brien S. Stroke genomics: approaches to identify, validate, and understand ischemic stroke gene expression. J Cereb Blood Flow Metab 2001;21:755-778
28. Danton GH, Dietrich WD. Inflammatory mechanisms after ischemia and stroke. J Neuropath Exp Neurol 2003;62:127-136
29. Ginsberg MD. Injury mechanisms in the ischemic penumbra. Approaches to neuroprotection in acute ischemic stroke. Cerebrovasc Dis 1997;7(Suppl 2):7-12
30. Millán M, Arenillas J. Gene expression in cerebral ischemia: a new approach for neuroprotection. Cerebrovasc Dis 2006;21(Suppl 2):30-37
31. Xerri C, Merzenich MM, Peterson BE, Jenkins W. Plasticity of primary somatosensory cortex paralleling sensorimotor skill recovery from stroke in adult monkeys. J Neurophysiol 1998;79:2119-2148
32. Kolb B, Gibb R, Gonzalez CL. Cortical injury and neuroplasticity during development. In Shaw C, McEachern JC (eds) Toward a Theory of Neuroplasticity. Philadelphia, Taylor & Francis; 2001, pp. 2223-2243
33. Beaulieu CL: Rehabilitation and outcome following pediatric traumatic brain injury. Surg Clin North Am 2002;82:393-408